MedBlog

Trials assess novel nanoparticle’s impact on brain cancer patients

Two studies underway at UT Southwestern are building upon existing nanoparticle technology to deliver brain cancer medications directly to the brain. Neurosurgeon Toral Patel, M.D., and Neuro-Oncologist Michael Youssef, M.D., discuss how the ReSPECT clinical trials may give hope to patients living with glioblastoma and leptomeningeal disease.

Toral Patel, M.D. / Michael Youssef, M.D.

July 12, 2024

Glowing tumors: How fluorescence helps neurosurgeons fight brain cancer

UT Southwestern's neurosurgery team recently performed the first two fluorescence-guided brain tumor removals in the Dallas-Fort Worth region, using an advanced technology that makes the cancer cells glow so it is easier to see and remove them. Kalil Abdullah, M.D., led the surgery team and discusses the effect of this advanced treatment for glioblastoma, the most common and aggressive form of brain tumor.

April 9, 2021